Sentence examples for value in progressing from inspiring English sources

According to Fisken and Rutherford (2002) this business model "aims to generate value in progressing products along the drug development process and either licensing them out to pharmaceutical and top tier biotechnology companies or taking them straight through to commercialization".   2.

If the number of false matches due to similar individuals having similar events is likely to make up a high proportion of achieved matches where accurate recording of data is assumed, then there is limited value in progressing further with the event-based method to resource-intensive studies which examine empirically the extent of all types of errors.

We must allow men and boys see value in progress and societal change that comes as a result of a shift in behaviors and traditions, and we must empower women and girls to feel safe, valued and respected.

End-of-grade assessments do have their place, but there is even greater value in incorporating progress-monitoring tools and formative assessments: they allow us to measure growth over time and give teachers necessary insight to intervene appropriately.

Additional investigations aiming to confirm this hypothesis and to evaluate a prognostic value are in progress.

They may also be of value in monitoring the progress of the disease.

In line with these findings, a recent published study has shown that clearance of inhaled 99mTc-DTPA is not of value in following the progress of IPF [ 17].

Second, efficient yet accurate instruments to measure depression would also be of considerable value in monitoring the progress of treatment by mental health specialists and other treating clinicians.

This study had the objective of evaluating the acute phase protein response of SAA and AGP in relation to that of Hp during experimentally-induced C. pseudotuberculosis infection, in order to determine their potential value in monitoring the progress of the disease.

A rapid increase of the CEC number as fast as the first cycle was associated with CTC decrease in non-progressed patients, whereas a delayed response of CECs was related to higher CTC values in the progressed group, suggesting that the antiendothelial targeting and the antitumour cells effects are strictly linked in vivo.

Synchronous detection of CTCs and CEC levels discloses for the first time an association between their dynamic changes and outcome: a rapid increase of the CEC number as early as the first cycle of therapy is associated with CTC decrease in non-progressed patients, whereas a delayed response of CECs is related to higher CTC values in the progressed group indicating treatment failure.